The agreement seeks to establish permanent relations between IBEC and the foundation to generate shared scientific and technological opportunities, as well as regulating research projects that the entities will develop together. Among other things, the collaboration provides for the exchange of scientific and technical staff, joint participation in scientific projects and shared development of innovative health interventions.
“This agreement, reached between two internationally renowned research centers, will enable synergies that can result in significant health advances in fields such as ophthalmology,” says Associate Director of IBEC Dr. Josep Samitier.
The Barcelona Macula Foundation conducts and support research on diseases of the retina and macula that cause blindness and that have no effective treatment, in order to restore or prevent the loss of vision. Its main focus of interest is macular and retinal degeneration, such as atrophic age-related macular degeneration, retinitis pigmentosa and Stargardt disease, for which there is currently no cure.
